Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2022 May 23;9(6):ofac180. doi: 10.1093/ofid/ofac180

Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies

E Moreno-García 1,#, P Puerta-Alcalde 2,#, G Gariup 3, M Fernández-Ruiz 4, L E López Cortés 5, G Cuervo 6, M Salavert 7, P Merino 8, M Machado 9, J Guinea 10, J García-Rodríguez 11, J Garnacho-Montero 12, C Cardozo 13, J Peman 14, M Montejo 15, J Fortún 16, B Almirante 17, C Castro 18, J Rodríguez-Baño 19, J M Aguado 20, J A Martínez 21, J Carratalà 22, A Soriano 23, C Garcia-Vidal 24,, Project from GEMICOMED (SEIMC)
PMCID: PMC9126489  PMID: 35615301

In the original publication of this manuscript [Moreno-García E, Puerta-Alcade E, Gariup G et al. Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies. Open Forum Infect Dis, Volume 8, Issue 6, June 2021. https://doi.org/10.1093/ofid/ofab250], the financial support section was incomplete and updated to read as follows: “This research forms part of an activity that has received funding from EIT Health. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union that receives support from the European Union´s Horizon 2020 Research and Innovation Program. This study has been co-funded by the European Regional Development Fund (EDRF, “A way to make Europe”). EM-G [PI18/01061], PP-A [“Juan Rodés” contract JR20/00012 and PI21/00498], MF-R [“Miguel Servet” contract CP18/00073], and CG-V [FIS PI15/00744] have received research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Contributor Information

E Moreno-García, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

P Puerta-Alcalde, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

G Gariup, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

M Fernández-Ruiz, Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (imas+12), Universidad Complutense, Madrid, Spain.

L E López Cortés, Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, CSIC, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.

G Cuervo, Hospital Universitari de Bellvitge, IDIBELL (Institut D’Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain.

M Salavert, Hospital Universitari i Politecnic “La Fe”, Valencia, Spain.

P Merino, Hospital Universitario Clínico “San Carlos”, Madrid, Spain.

M Machado, Hospital General Universitario Gregorio Marañón e Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.

J Guinea, Hospital General Universitario Gregorio Marañón e Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.

J García-Rodríguez, Hospital Universitario “La Paz”, Madrid, Spain.

J Garnacho-Montero, Unidad Clínica de Cuidados Intensivos, Hospital Universitario “Virgen Macarena”, Sevilla, Spain.

C Cardozo, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

J Peman, Hospital Universitari i Politecnic “La Fe”, Valencia, Spain.

M Montejo, Hospital Universitario “Cruces”, Bilbao, Spain.

J Fortún, Hospital Universitario “Ramón y Cajal”, Madrid, Spain.

B Almirante, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

C Castro, Hospital Universitario de Valme, Sevilla, Spain.

J Rodríguez-Baño, Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, CSIC, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.

J M Aguado, Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (imas+12), Universidad Complutense, Madrid, Spain.

J A Martínez, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

J Carratalà, Hospital Universitari de Bellvitge, IDIBELL (Institut D’Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain.

A Soriano, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

C Garcia-Vidal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.


Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES